QUINLAN KEVIN W 4
4 · ANIKA THERAPEUTICS INC · Filed Jan 28, 2010
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Award
Stock Appreciation Rights
2010-01-26+25,000→ 25,000 totalExercise: $6.36Exp: 2020-01-26→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in four equal installments annually beginning January 26, 2011.